Skip to main content

Table 5 Fibrosis categories of the study groups (SVR and NR)

From: Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients

 

Early fibrosis (F0–F1)

Late fibrosis (F2–F3)

Treatment response

  

•Patients who achieved SVR12 (responders)

103 (73.04%)

38 (26.95%)

•Patients who did not achieve SVR12 (non- responders)

0 (0%)

9 (100%)

p value

< 0.001*

< 0.001*